Reduced Graphene Oxide Fibers Combined with Electrical Stimulation Promote Peripheral Nerve Regeneration
Yuanyuan Zhao,Yang Liu,Cheng Lu,Daokuan Sun,Shiqi Kang,Xin Wang,Laijin Lu
DOI: https://doi.org/10.2147/ijn.s449160
IF: 7.033
2024-03-08
International Journal of Nanomedicine
Abstract:Yuanyuan Zhao, 1 Yang Liu, 1 Cheng Lu, 1 Daokuan Sun, 2 Shiqi Kang, 1 Xin Wang, 2, &ast Laijin Lu 1, &ast 1 Department of Hand and Podiatric Surgery, Orthopedics Center, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China; 2 School of Materials Science and Engineering, Jilin University, Changchun, Jilin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Laijin Lu, Department of Hand and Podiatric Surgery, Orthopedics Center, The First Hospital of Jilin University, Changchun, Jilin, People's Republic of China, Tel +86-13756661203, Fax +86 431 84808391, Email Xin Wang, School of Materials Science and Engineering, Jilin University, Changchun, Jilin, People's Republic of China, Tel +86-18 626 655 395, Fax +86 431 84 808 391, Email Background: The treatment of long-gap peripheral nerve injury (PNI) is still a substantial clinical problem. Graphene-based scaffolds possess extracellular matrix (ECM) characteristic and can conduct electrical signals, therefore have been investigated for repairing PNI. Combined with electrical stimulation (ES), a well performance should be expected. We aimed to determine the effects of reduced graphene oxide fibers (rGOFs) combined with ES on PNI repair in vivo. Methods: rGOFs were prepared by one-step dimensionally confined hydrothermal strategy (DCH). Surface characteristics, chemical compositions, electrical and mechanical properties of the samples were characterized. The biocompatibility of the rGOFs were systematically explored both in vitro and in vivo. Total of 54 Sprague-Dawley (SD) rats were randomized into 6 experimental groups: a silicone conduit (S), S+ES, S+rGOFs-filled conduit (SGC), SGC+ES, nerve autograft, and sham groups for a 10-mm sciatic defect. Functional and histological recovery of the regenerated sciatic nerve at 12 weeks after surgery in each group of SD rats were evaluated. Results: rGOFs exhibited aligned micro- and nano-channels with excellent mechanical and electrical properties. They are biocompatible in vitro and in vivo. All 6 groups exhibited PNI repair outcomes in view of neurological and morphological recovery. The SGC+ES group achieved similar therapeutic effects as nerve autograft group ( P > 0.05), significantly outperformed other treatment groups. Immunohistochemical analysis showed that the expression of proteins related to axonal regeneration and angiogenesis were relatively higher in the SGC+ES. Conclusion: The rGOFs had good biocompatibility combined with excellent electrical and mechanical properties. Combined with ES, the rGOFs provided superior motor nerve recovery for a 10-mm nerve gap in a murine acute transection injury model, indicating its excellent repairing ability. That the similar therapeutic effects as autologous nerve transplantation make us believe this method is a promising way to treat peripheral nerve defects, which is expected to guide clinical practice in the future. Keywords: peripheral nerve defects, sciatic nerve injury, functional recovery, tissue engineering, conductive materials PNI is a common and high-incidence disease in clinical practice that is mostly caused by accidental trauma and local lesions. 1,2 The lack of timely and effective treatment often leads to long-term sensory and motor dysfunction in many patients, especially those with long-gap peripheral nerve defects, thus seriously affecting their quality of life and imposing a heavy burden on social services. Autologous nerve transplantation is the most widely used neurosurgical approach, but encounters such problems as a shortage of donors, difficulty in adapting to the size of the nerve, and secondary damage to the donor area. 3,4 Nerve guide conduits (NGCs) have received widespread attention in recent years and some of these conduits have been approved by the Food and Drug Administration (FDA) and were applied to clinical patients, even though a poor recovery of the sensory or motor function in comparison with nerve autografts still remained. 5–10 As the first generation of implanted conduit, silicon tube has many advantages such as biocompatible, low cost, processability, inert and flexible characteristics. However, lacking of the ability of transmission of electrical stimuli and non-degradability are its obvious intrinsic disadvantages. 11,12 Comparatively, conductive materials revealed promising capability to stimulate cellular activity with or without external ES, therefore, developing a new generation of stimulus-responsive scaffolds have received great attention in modulating neuron cell functions and pro -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology